KE3052A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number: KE3052A
Authority: KE; Kenya
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1974-03-28

Application number

KE3052A

Other languages

English (en)

Inventor

R James

Roger James

Original Assignee

Ici Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-03-28

Filing date

1980-06-05

Publication date

1980-06-27

1980-06-05 Application filed by Ici Ltd filed Critical Ici Ltd

1980-06-27 Publication of KE3052A publication Critical patent/KE3052A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Health & Medical Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Biophysics (AREA)
Dispersion Chemistry (AREA)
Biochemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

KE3052A 1974-03-28 1980-06-05 Pharmaceutical compositions KE3052A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB1373974A GB1472793A (en)	1974-03-28	1974-03-28	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
KE3052A true KE3052A (en)	1980-06-27

Family

ID=10028495

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KE3052A KE3052A (en)	1974-03-28	1980-06-05	Pharmaceutical compositions

Country Status (22)

Country	Link
US (2)	US4056635A (da)
JP (1)	JPS50154410A (da)
AU (1)	AU502164B2 (da)
BE (1)	BE827290A (da)
CA (1)	CA1038764A (da)
DE (1)	DE2513797C2 (da)
DK (1)	DK128675A (da)
DO (1)	DOP1980002892A (da)
FI (1)	FI750941A (da)
FR (1)	FR2265357B1 (da)
GB (1)	GB1472793A (da)
HK (1)	HK34380A (da)
IE (1)	IE40839B1 (da)
IL (1)	IL46899A (da)
KE (1)	KE3052A (da)
MY (1)	MY8100111A (da)
NL (2)	NL183079C (da)
NO (1)	NO751076L (da)
NZ (1)	NZ177023A (da)
PH (1)	PH13553A (da)
SE (1)	SE7503542L (da)
ZA (1)	ZA751806B (da)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6005001A (en) *	1991-05-20	1999-12-21	Novartis Ag (Formerly Sandoz Ag)	Pharmaceutical composition
HU223343B1 (hu) *	1991-05-20	2004-06-28	Novartis Ag.	Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US5916596A (en) *	1993-02-22	1999-06-29	Vivorx Pharmaceuticals, Inc.	Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5731355A (en) *	1994-03-22	1998-03-24	Zeneca Limited	Pharmaceutical compositions of propofol and edetate
GB9405593D0 (en) *	1994-03-22	1994-05-11	Zeneca Ltd	Pharmaceutical compositions
US20020173547A1 (en)	1994-03-22	2002-11-21	Jones Christopher Buchan	Pharmaceuticals compositions
MY113046A (en) *	1994-03-22	2001-11-30	Astrazeneca Uk Ltd	Pharmaceutical compositions
IT1269977B (it)	1994-07-01	1997-04-16	Archimica Spa	Purificazione del propofol
IT1270093B (it) *	1994-09-28	1997-04-28	Zambon Spa	Processo per la purificazione di 2,6-diisopropilfenolo
CN1106192C (zh) *	1995-03-17	2003-04-23	曾尼卡有限公司	含2,6－二异丙基苯酚和乙二胺四乙酸盐的水包油型乳液
CN100512877C (zh) *	1995-03-17	2009-07-15	曾尼卡有限公司	无菌医药组合物
AU6708096A (en) *	1995-09-18	1997-04-09	Vesifact Ag	Propofol nanodispersions
DE69637441T2 (de)	1995-10-17	2009-03-05	Jagotec Ag	Verabreichung unlöslicher arzneistoffe
US5637625A (en) *	1996-03-19	1997-06-10	Research Triangle Pharmaceuticals Ltd.	Propofol microdroplet formulations
US6465016B2 (en)	1996-08-22	2002-10-15	Research Triangle Pharmaceuticals	Cyclosporiine particles
US7255877B2 (en)	1996-08-22	2007-08-14	Jagotec Ag	Fenofibrate microparticles
DE19709704C2 (de) *	1997-03-10	1999-11-04	Michael Georgieff	Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
CH692322A5 (it)	1997-05-26	2002-05-15	Westy Ag	Formulazione iniettabile limpida di Propofol.
US8853260B2 (en) *	1997-06-27	2014-10-07	Abraxis Bioscience, Llc	Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
DE19757224A1 (de)	1997-12-22	1999-07-01	Bayer Ag	Verfahren und Vorrichtung zur in-situ-Formulierung einer Arzneistofflösung zur parenteralen Applikation
BR9907832A (pt) *	1998-02-10	2000-10-31	Sicor Inc	Composição de propofol contendo sulfito
ATE241363T1 (de) *	1998-02-11	2003-06-15	Rtp Pharma Corp	Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen
US6979456B1 (en)	1998-04-01	2005-12-27	Jagotec Ag	Anticancer compositions
EP1079808B1 (en)	1998-05-29	2004-02-11	Skyepharma Canada Inc.	Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
WO2000010531A1 (en)	1998-08-19	2000-03-02	Rtp Pharma Inc.	Injectable aqueous dispersions of propofol
US6150423A (en)	1998-10-15	2000-11-21	Phoenix Scientific, Inc.	Propofol-based anesthetic and method of making same
US6028108A (en) *	1998-10-22	2000-02-22	America Home Products Corporation	Propofol composition comprising pentetate
US6140374A (en) *	1998-10-23	2000-10-31	Abbott Laboratories	Propofol composition
CZ20011739A3 (cs)	1998-11-20	2001-10-17	Rtp Pharma Inc.	Dispergovatelné fosfolipidem stabilizované mikročástice
US6177477B1 (en) *	1999-03-24	2001-01-23	American Home Products Corporation	Propofol formulation containing TRIS
US6100302A (en)	1999-04-05	2000-08-08	Baxter International Inc.	Propofol formulation with enhanced microbial characteristics
CN1149984C (zh) *	1999-06-21	2004-05-19	健一制药株式会社	用于静脉注射的含有普鲁泊福的麻醉组合物
GB2359747B (en) *	2000-02-29	2002-04-24	Maelor Pharmaceuticals Ltd	Anaesthetic formulations
KR100386397B1 (ko) *	2000-04-19	2003-06-02	센츄론(주)	투명한 프로포폴 주사제
JP5102423B2 (ja)	2000-04-20	2012-12-19	オバン・エナジー・リミテッド	改善された水不溶性薬剤粒子の処理
AU6689601A (en)	2000-06-16	2002-01-02	Rtp Pharma Inc	Improved injectable dispersions of propofol
DE10041479A1 (de) *	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10041478A1 (de)	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	Neue pharmazeutische Zusammensetzung
EP1313451B1 (en)	2000-08-31	2009-03-11	Jagotec AG	Milled particles
US8586094B2 (en)	2000-09-20	2013-11-19	Jagotec Ag	Coated tablets
US6977085B2 (en) *	2000-12-22	2005-12-20	Baxter International Inc.	Method for preparing submicron suspensions with polymorph control
US6869617B2 (en) *	2000-12-22	2005-03-22	Baxter International Inc.	Microprecipitation method for preparing submicron suspensions
US20040256749A1 (en) *	2000-12-22	2004-12-23	Mahesh Chaubal	Process for production of essentially solvent-free small particles
US6884436B2 (en) *	2000-12-22	2005-04-26	Baxter International Inc.	Method for preparing submicron particle suspensions
US6951656B2 (en) *	2000-12-22	2005-10-04	Baxter International Inc.	Microprecipitation method for preparing submicron suspensions
US20040022862A1 (en) *	2000-12-22	2004-02-05	Kipp James E.	Method for preparing small particles
US20030072807A1 (en) *	2000-12-22	2003-04-17	Wong Joseph Chung-Tak	Solid particulate antifungal compositions for pharmaceutical use
US9700866B2 (en)	2000-12-22	2017-07-11	Baxter International Inc.	Surfactant systems for delivery of organic compounds
US20030096013A1 (en) *	2000-12-22	2003-05-22	Jane Werling	Preparation of submicron sized particles with polymorph control
US8067032B2 (en) *	2000-12-22	2011-11-29	Baxter International Inc.	Method for preparing submicron particles of antineoplastic agents
US20050048126A1 (en)	2000-12-22	2005-03-03	Barrett Rabinow	Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US7193084B2 (en) *	2000-12-22	2007-03-20	Baxter International Inc.	Polymorphic form of itraconazole
ATE357216T1 (de) *	2001-02-22	2007-04-15	Jagotec Ag	Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
US7244703B2 (en)	2001-06-22	2007-07-17	Bentley Pharmaceuticals, Inc.	Pharmaceutical compositions and methods for peptide treatment
JP4127757B2 (ja) *	2001-08-21	2008-07-30	株式会社エヌ・ティ・ティ・ドコモ	無線通信システム、通信端末装置、及びバースト信号送信方法
GB0120702D0 (en) *	2001-08-24	2001-10-17	Maelor Pharmaceuticals Ltd	Anaesthetic formulations
US6815555B2 (en)	2001-09-26	2004-11-09	Theravance, Inc.	Substituted phenol compounds useful for anesthesia and sedation
US20060003012A9 (en)	2001-09-26	2006-01-05	Sean Brynjelsen	Preparation of submicron solid particle suspensions by sonication of multiphase systems
JP2005504090A (ja)	2001-09-26	2005-02-10	バクスター・インターナショナル・インコーポレイテッド	分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
GB0124071D0 (en) *	2001-10-08	2001-11-28	Kbig Ltd	Improvement in the administration of high boiling point aneasthetics
US7112340B2 (en) *	2001-10-19	2006-09-26	Baxter International Inc.	Compositions of and method for preparing stable particles in a frozen aqueous matrix
JP3931680B2 (ja) *	2002-02-18	2007-06-20	株式会社日本自動車部品総合研究所	車両の直進判別装置
US20040220283A1 (en) *	2002-07-29	2004-11-04	Transform Pharmaceuticals, Inc.	Aqueous 2,6-diisopropylphenol pharmaceutical compositions
KR101145692B1 (ko) *	2002-07-29	2012-05-25	트렌스폼 파마수티컬스 인코퍼레이티드	수성 2,6-디이소프로필페놀 약제학적 조성물
US7550155B2 (en) *	2002-07-29	2009-06-23	Transform Pharmaceuticals Inc.	Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
EP1555976A4 (en) *	2002-10-29	2007-11-14	Transform Pharmaceuticals Inc	PROPOFOL ASSOCIATED WITH CYSTEINE
EP1556022A4 (en) *	2002-10-29	2010-03-10	Transform Pharmaceuticals Inc	AQUEOUS PHARMACEUTICAL COMPOSITIONS 2,6-DIISOPROPYLPHENOL
WO2004048332A1 (ja)	2002-11-26	2004-06-10	Maruishi Pharmaceutical Co., Ltd.	イソインドリン誘導体
US20040225022A1 (en) *	2003-05-09	2004-11-11	Desai Neil P.	Propofol formulation containing reduced oil and surfactants
US8476010B2 (en)	2003-07-10	2013-07-02	App Pharmaceuticals Llc	Propofol formulations with non-reactive container closures
US8546453B2 (en)	2003-08-14	2013-10-01	Rensheng Zhang	Propofol compositions and methods for reducing pain associated with propofol injection
ITMI20032054A1 (it) *	2003-10-22	2005-04-23	Monteres S R L	Processo per la preparazione di sospensioni farmaceutiche da inalare.
WO2005056038A1 (en)	2003-12-08	2005-06-23	Bentley Pharmaceuticals, Inc.	Pharmaceutical compositions and methods for insulin treatment
JP2007520555A (ja) *	2004-02-05	2007-07-26	バクスター・インターナショナル・インコーポレイテッド	自己安定化剤の使用により調製された分散剤
MX2007015183A (es) *	2005-06-14	2008-02-19	Baxter Int	Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
US20060280787A1 (en) *	2005-06-14	2006-12-14	Baxter International Inc.	Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
US20100048732A1 (en) *	2006-05-30	2010-02-25	Emala Sr Charles W	Method of mediating Airway Smooth Muscle Construction Due to Airway Irritation
WO2008008492A2 (en) *	2006-07-13	2008-01-17	University Of Iowa Research Fdtn.	Hydrofluoroalkyl phenols having anesthetic properties
WO2008080047A2 (en) *	2006-12-23	2008-07-03	Baxter International Inc.	Magnetic separation of fine particles from compositions
CN101687746A (zh) *	2007-05-09	2010-03-31	法莫科佛股份有限公司	治疗性组合物
JP5651009B2 (ja) *	2007-05-09	2015-01-07	ソウッドヘルスケアエルエルシー	治療用化合物
US8722736B2 (en)	2007-05-22	2014-05-13	Baxter International Inc.	Multi-dose concentrate esmolol with benzyl alcohol
US8426467B2 (en)	2007-05-22	2013-04-23	Baxter International Inc.	Colored esmolol concentrate
US20080293814A1 (en) *	2007-05-22	2008-11-27	Deepak Tiwari	Concentrate esmolol
US20090198145A1 (en) *	2008-02-06	2009-08-06	Chow Harrison	Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
US20180022698A1 (en)	2014-10-16	2018-01-25	The Board Of Trustees Of The Leland Stanford Junior University	Novel methods, compounds, and compositions for anesthesia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2104412A (en) *	1931-12-29	1938-01-04	Standard Oil Dev Co	Alkyl phenols
GB831071A (en)	1956-04-26	1960-03-23	British Schering Ltd	Analgesic compounds
GB803080A (en)	1956-07-06	1958-10-15	Scient Oil Compounding Co Inc	Bacteriostatic compositions
US2966442A (en) *	1956-09-20	1960-12-27	American Home Prod	Antibiotic compositions
US3476838A (en) *	1958-12-04	1969-11-04	Ethyl Corp	Di(2,6-diisopropylphenyl) mono halo phosphite or (thio) phosphate
US3067106A (en) *	1959-04-07	1962-12-04	Foundation For Prosthetic Res	Skin treating method and composition

1974
- 1974-03-28 GB GB1373974A patent/GB1472793A/en not_active Expired
1975
- 1975-03-18 IE IE587/75A patent/IE40839B1/xx not_active IP Right Cessation
- 1975-03-19 US US05/559,880 patent/US4056635A/en not_active Expired - Lifetime
- 1975-03-21 ZA ZA00751806A patent/ZA751806B/xx unknown
- 1975-03-21 CA CA222,804A patent/CA1038764A/en not_active Expired
- 1975-03-24 IL IL46899A patent/IL46899A/xx unknown
- 1975-03-24 NZ NZ177023A patent/NZ177023A/xx unknown
- 1975-03-25 DK DK128675A patent/DK128675A/da not_active Application Discontinuation
- 1975-03-26 PH PH16980A patent/PH13553A/en unknown
- 1975-03-26 NO NO751076A patent/NO751076L/no unknown
- 1975-03-26 AU AU79536/75A patent/AU502164B2/en not_active Ceased
- 1975-03-26 SE SE7503542A patent/SE7503542L/ unknown
- 1975-03-27 FR FR7509683A patent/FR2265357B1/fr not_active Expired
- 1975-03-27 NL NLAANVRAGE7503696,A patent/NL183079C/xx active Protection Beyond IP Right Term
- 1975-03-27 BE BE154864A patent/BE827290A/xx not_active IP Right Cessation
- 1975-03-27 FI FI750941A patent/FI750941A/fi not_active Application Discontinuation
- 1975-03-27 DE DE2513797A patent/DE2513797C2/de not_active Expired
- 1975-03-28 JP JP50037699A patent/JPS50154410A/ja active Pending
1977
- 1977-09-19 US US05/834,292 patent/US4452817A/en not_active Expired - Lifetime
1980
- 1980-06-05 KE KE3052A patent/KE3052A/xx unknown
- 1980-06-26 HK HK343/80A patent/HK34380A/xx unknown
- 1980-08-01 DO DO1980002892A patent/DOP1980002892A/es unknown
1981
- 1981-12-30 MY MY111/81A patent/MY8100111A/xx unknown
1993
- 1993-06-22 NL NL930084C patent/NL930084I2/nl unknown

Also Published As

Publication number	Publication date
US4056635A (en)	1977-11-01
ZA751806B (en)	1976-02-25
FR2265357A1 (fr)	1975-10-24
DE2513797C2 (de)	1987-07-30
AU502164B2 (en)	1979-07-12
FI750941A (da)	1975-09-29
JPS50154410A (da)	1975-12-12
BE827290A (fr)	1975-09-29
DK128675A (de)	1975-09-29
MY8100111A (da)	1981-12-31
DOP1980002892A (es)	1989-10-04
IL46899A0 (en)	1975-06-25
AU7953675A (en)	1976-09-30
DE2513797A1 (de)	1975-10-09
US4452817A (en)	1984-06-05
HK34380A (en)	1980-07-01
CA1038764A (en)	1978-09-19
IE40839L (en)	1975-09-28
NZ177023A (en)	1984-09-28
NL183079C (nl)	1988-07-18
NO751076L (da)	1975-09-30
PH13553A (en)	1980-06-26
NL7503696A (nl)	1975-09-30
IL46899A (en)	1978-03-10
FR2265357B1 (fr)	1978-08-04
SE7503542L (da)	1975-09-29
IE40839B1 (en)	1979-08-29
GB1472793A (en)	1977-05-04
NL930084I2 (nl)	1994-10-17
NL930084I1 (nl)	1993-09-16

Publication	Publication Date	Title
ZA751806B (en)	1976-02-25	Pharmaceutical compositions
NZ179495A (en)	1978-06-20	1-substituted-4-benzylpiperidines and pharmaceutical compositions
ZA74385B (en)	1975-08-27	Pharmaceutical compositions
ZA756572B (en)	1977-05-25	Shampoo compositions
ZA755998B (en)	1976-08-25	Pharmaceutical compositions
IL48508A (en)	1979-10-31	Pharmaceutical compositions comprising piperidylindole derivatives
AU487061B2 (en)	1976-01-08	Pharmaceutical compositions
PH12058A (en)	1978-10-18	Antibiotic pharmaceutical compositions
IL46965A (en)	1978-07-31	Pharmaceutical composition containing heparinoidic factor
AU8293375A (en)	1977-01-13	Uv-photopolymerizable compositions
HK17281A (en)	1981-05-08	Pharmaceutical compositions
NZ179502A (en)	1979-01-11	Ii-desoxy-omega-tetra norprostaglanding internediates pharmaceutical composition
ZA755802B (en)	1976-08-25	Pharmaceutical compositions
IL48098A0 (en)	1975-11-25	Pharmaceutical compositions containing diphenylethanol derivatives
HK73178A (en)	1978-12-22	Pharmaceutical compositions
PH12855A (en)	1979-09-12	Pharmaceutical compositions
ZM12375A1 (en)	1976-12-21	Compositions
ZA755515B (en)	1976-08-25	Pharmaceutical formulations
NZ178962A (en)	1978-03-06	1-aryloxy-4-amino-2-butanols and pharmaceutical compositions
ZA757067B (en)	1976-11-24	Pharmaceutical compositions comprising substituted 4,6-dihydroxy-2h-pyran-2-ones
ZA755904B (en)	1976-07-28	Pharmaceutical compositions
IE39123B1 (en)	1978-08-02	Pharmaceutical compositions
ZA742246B (en)	1975-03-26	Pharmaceutical compositions
ZA744340B (en)	1975-07-30	Pharmaceutical compositions
ZA756921B (en)	1976-09-29	Pharmaceutical compositions